485 related articles for article (PubMed ID: 24994071)
1. Hepatic, intestinal, renal, and plasma hydrolysis of prodrugs in human, cynomolgus monkey, dog, and rat: implications for in vitro-in vivo extrapolation of clearance of prodrugs.
Nishimuta H; Houston JB; Galetin A
Drug Metab Dispos; 2014 Sep; 42(9):1522-31. PubMed ID: 24994071
[TBL] [Abstract][Full Text] [Related]
2. Different hydrolases involved in bioactivation of prodrug-type angiotensin receptor blockers: carboxymethylenebutenolidase and carboxylesterase 1.
Ishizuka T; Yoshigae Y; Murayama N; Izumi T
Drug Metab Dispos; 2013 Nov; 41(11):1888-95. PubMed ID: 23946449
[TBL] [Abstract][Full Text] [Related]
3. Quantitative Prediction of Human Hepatic Clearance for P450 and Non-P450 Substrates from In Vivo Monkey Pharmacokinetics Study and In Vitro Metabolic Stability Tests Using Hepatocytes.
Nishimuta H; Watanabe T; Bando K
AAPS J; 2019 Jan; 21(2):20. PubMed ID: 30673906
[TBL] [Abstract][Full Text] [Related]
4. Species differences in hepatic and intestinal metabolic activities for 43 human cytochrome P450 substrates between humans and rats or dogs.
Nishimuta H; Nakagawa T; Nomura N; Yabuki M
Xenobiotica; 2013 Nov; 43(11):948-55. PubMed ID: 23593983
[TBL] [Abstract][Full Text] [Related]
5. Hepatic Organic Anion Transporting Polypeptide-Mediated Clearance in the Beagle Dog: Assessing In Vitro-In Vivo Relationships and Applying Cross-Species Empirical Scaling Factors to Improve Prediction of Human Clearance.
Matsunaga N; Ufuk A; Morse BL; Bedwell DW; Bao J; Mohutsky MA; Hillgren KM; Hall SD; Houston JB; Galetin A
Drug Metab Dispos; 2019 Mar; 47(3):215-226. PubMed ID: 30593544
[TBL] [Abstract][Full Text] [Related]
6. In vitro hydrolysis and transesterification of CDP323, an α4β1/α4β7 integrin antagonist ester prodrug.
Chanteux H; Rosa M; Delatour C; Prakash C; Smith S; Nicolas JM
Drug Metab Dispos; 2014 Jan; 42(1):153-61. PubMed ID: 24179032
[TBL] [Abstract][Full Text] [Related]
7. Prediction of human drug clearance by multiple metabolic pathways: integration of hepatic and intestinal microsomal and cytosolic data.
Cubitt HE; Houston JB; Galetin A
Drug Metab Dispos; 2011 May; 39(5):864-73. PubMed ID: 21303923
[TBL] [Abstract][Full Text] [Related]
8. Interspecies Differences in the Metabolism of a Multiester Prodrug by Carboxylesterases.
Fu J; Pacyniak E; Leed MGD; Sadgrove MP; Marson L; Jay M
J Pharm Sci; 2016 Feb; 105(2):989-995. PubMed ID: 26344572
[TBL] [Abstract][Full Text] [Related]
9. Identification of carboxylesterases expressed in rat intestine and effects of their hydrolyzing activity in predicting first-pass metabolism of ester prodrugs.
Liu D; Gao J; Zhang C; Ren X; Liu Y; Xu Y
Pharmazie; 2011 Nov; 66(11):888-93. PubMed ID: 22204136
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the expression and activity of carboxylesterases 1 and 2 from the beagle dog, cynomolgus monkey, and human.
Williams ET; Bacon JA; Bender DM; Lowinger JJ; Guo WK; Ehsani ME; Wang X; Wang H; Qian YW; Ruterbories KJ; Wrighton SA; Perkins EJ
Drug Metab Dispos; 2011 Dec; 39(12):2305-13. PubMed ID: 21918037
[TBL] [Abstract][Full Text] [Related]
11. Predicting Human Clearance of Organic Anion Transporting Polypeptide Substrates Using Cynomolgus Monkey: In Vitro-In Vivo Scaling of Hepatic Uptake Clearance.
De Bruyn T; Ufuk A; Cantrill C; Kosa RE; Bi YA; Niosi M; Modi S; Rodrigues AD; Tremaine LM; Varma MVS; Galetin A; Houston JB
Drug Metab Dispos; 2018 Jul; 46(7):989-1000. PubMed ID: 29720472
[TBL] [Abstract][Full Text] [Related]
12. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
Kamath AV; Wang J; Lee FY; Marathe PH
Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance.
McGinnity DF; Soars MG; Urbanowicz RA; Riley RJ
Drug Metab Dispos; 2004 Nov; 32(11):1247-53. PubMed ID: 15286053
[TBL] [Abstract][Full Text] [Related]
14. Species differences for stereoselective hydrolysis of propranolol prodrugs in plasma and liver.
Yoshigae Y; Imai T; Horita A; Otagiri M
Chirality; 1997; 9(7):661-6. PubMed ID: 9366026
[TBL] [Abstract][Full Text] [Related]
15. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, disposition and lipid-modulating activity of 5-{2-[4-(3,4-difluorophenoxy)-phenyl]-ethylsulfamoyl}-2-methyl-benzoic acid, a potent and subtype-selective peroxisome proliferator-activated receptor alpha agonist in preclinical species and human.
Frederick KS; Maurer TS; Kalgutkar AS; Royer LJ; Francone OL; Winter SM; Terra SG; Chen D; Gao X
Xenobiotica; 2009 Oct; 39(10):766-81. PubMed ID: 19622022
[TBL] [Abstract][Full Text] [Related]
17. Arylacetamide Deacetylase is Responsible for Activation of Prasugrel in Human and Dog.
Kurokawa T; Fukami T; Yoshida T; Nakajima M
Drug Metab Dispos; 2016 Mar; 44(3):409-16. PubMed ID: 26718653
[TBL] [Abstract][Full Text] [Related]
18. Sigmoidal kinetics of CYP3A substrates: an approach for scaling dextromethorphan metabolism in hepatic microsomes and isolated hepatocytes to predict in vivo clearance in rat.
Witherow LE; Houston JB
J Pharmacol Exp Ther; 1999 Jul; 290(1):58-65. PubMed ID: 10381760
[TBL] [Abstract][Full Text] [Related]
19. In vitro hepatic metabolism of cediranib, a potent vascular endothelial growth factor tyrosine kinase inhibitor: interspecies comparison and human enzymology.
Schulz-Utermoehl T; Spear M; Pollard CR; Pattison C; Rollison H; Sarda S; Ward M; Bushby N; Jordan A; Harrison M
Drug Metab Dispos; 2010 Oct; 38(10):1688-97. PubMed ID: 20634336
[TBL] [Abstract][Full Text] [Related]
20. Deciphering the species differences in CES1A-mediated hydrolytic metabolism by using a bioluminescence substrate.
Jin Q; Li Z; Zhang MJ; Liu WC; Zou LW; Sui H; Wang DD; Tang QF; Ge GB
Chem Biol Interact; 2022 Dec; 368():110197. PubMed ID: 36174736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
